Abstract | BACKGROUND: Two to four percentage of infants are affected by cow's milk allergy (CMA), which persists in 20% of cases. Intervention approaches using early oral exposure to cow's milk protein or hydrolysed cow's milk formula are being studied for CMA prevention. Yet, concerns regarding safety and/or efficacy remain to be tackled in particular for high-risk non-exclusively breastfed infants. Therefore, safe and effective strategies to improve early life oral tolerance induction may be considered. OBJECTIVE: METHODS: The peptides were loaded in PLGA NPs via a double emulsion solvent evaporation technique. In vivo, 3-week-old female C3H/HeOuJ mice received 6 daily gavages with PBS, whey, Peptide-mix, a high- or low-dose Peptide-NPs or empty-NP plus Peptide-mix, prior to 5 weekly oral sensitizations with cholera toxin plus whey or PBS ( sham). One week after the last sensitization, the challenge induced acute allergic skin response, anaphylactic shock score, allergen-specific serum immunoglobulins and ex vivo whey-stimulated cytokine release by splenocytes was measured. RESULTS: Mice pre-treated with high-dose Peptide-NPs but not low-dose or empty-NP plus Peptide-mix, were protected from anaphylaxis and showed a significantly lower acute allergic skin response upon intradermal whey challenge compared to whey-sensitized mice. Compared with the Peptide-mix or empty-NP plus Peptide-mix pre-treatment, the high-dose Peptide-NPs-pre-treatment inhibited ex vivo whey-stimulated pro-inflammatory cytokine TNF-α release by splenocytes. CONCLUSION & CLINICAL RELEVANCE: Oral pre-exposure of mice to two β- lactoglobulin-derived peptides loaded PLGA NPs induced a dose-related partial prevention of CMA symptoms upon challenge to whole whey protein and silenced whey-specific systemic immune response. These findings encourage further development of the concept of peptide-loaded PLGA NPs for CMA prevention towards clinical application.
|
Authors | Mengshan Liu, Suzan Thijssen, Cornelus F van Nostrum, Wim E Hennink, Johan Garssen, Linette E M Willemsen |
Journal | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
(Clin Exp Allergy)
Vol. 52
Issue 1
Pg. 137-148
(01 2022)
ISSN: 1365-2222 [Electronic] England |
PMID | 34145667
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. |
Chemical References |
- Cytokines
- Lactoglobulins
- Milk Proteins
- Whey Proteins
|
Topics |
- Animals
- Cattle
- Cytokines
(metabolism)
- Disease Models, Animal
- Female
- Humans
- Lactoglobulins
- Mice
- Mice, Inbred C3H
- Milk Hypersensitivity
- Milk Proteins
- Nanoparticles
- Whey
(metabolism)
- Whey Proteins
|